Apheresis and intravenous immunoglobulins used in addition to conventional therapy to treat high-risk pregnant antiphospholipid antibody syndrome patients. A prospective study - Ruffatti, A; Favaro, M; Hoxha, A (J Reprod Immunol, 2016)
, et al.